Status | Study |
Completed |
Study Name: Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability Condition: Eye Pain Date: 2017-02-21 Interventions: Drug: Loteprednol Etabonate Ophthalmic Gel Formulated LE into a gel (loteprednol etabonate ophthalmic ge |
Not yet recruiting |
Study Name: Study of SAF312 as an Eye Drop for Treatment of Eye Pain Following Photorefractive Keratectomy (PRK) Surgery Condition: Postoperative Ocular Pain After PRK Surgery Date: 2016-11-08 Interventions: Drug: SAF312 Drug: Placebo |
Recruiting |
Study Name: Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER) Condition: Optic Neuritis Date: 2015-08-10 Interventions: Drug: Clemastine 12mg (4mg 3x/ |
Completed |
Study Name: Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain Condition: Ocular Pain Dry Eye Syndrome Date: 2015-05-20 Interventions: Drug: SYL1001 SYL1001 eye drop |
Completed |
Study Name: RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD Condition: Corneal Endothelial Cell Loss Ocular Pain Date: 2014-04-28 Interventions: Drug: Placebo Opthalmic suspen |
Completed |
Study Name: RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery Condition: Inflammation and Pain Following Ocular Surgery Date: 2014-02-13 Interventions: Drug: RTA 408 0.5% Ophthalmic Suspension D |
Completed |
Study Name: Pain Expression in the Perioperative Period of Cataract Surgery Condition: Cataract Surgery Eye Pain Date: 2013-04-02 Interventions: Procedure: First eye (FE) Phac |
Completed |
Study Name: Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain Condition: Ocular Pain Dry Eye Syndrome Date: 2012-11-14 Interventions: Drug: SYL1001 Ocular topical a |
Completed |
Study Name: Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers Condition: Ocular Pain Dry Eye Date: 2011-09-14 Interventions: Drug: SYL1001 SYL1001 eye drops. topical administration |
Completed |
Study Name: Nepafenac Compared to Placebo for Ocular Pain and Inflammation Condition: Cataract Date: 2011-08-30 Interventions: Drug: Nepafenac Ophthalmic Suspension, 0.1% |